7826-full
supasonic
Sex: M
Data Quality: 0 stars
ALS: 1 yr
Bi-Pap Wheelchair
Bulbar: severe
Arms: severe
Chest: moderate
Legs: severe
supasonic
Male, 29 years
St. Gallen, SG
Primary Condition
ALS
First symptom
Diagnosis
Deceased
May 13, 2009
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

supasonic's Madopar is for:

supasonic's side effects of Madopar:

supasonic's Madopar History (Stopped)
Madopar (levodopa-benserazide)
185 mg Daily Dec 12 - 20, 2008
750 mg Daily Dec 20 - 24, 2008
1500 mg Daily Dec 24, 2008 - Jan 18, 2009
Stopped Did not seem to work Jan 18, 2009
Evaluations
Date Dosage Stiffness/Spasticity Perceived effectiveness Side Effects Adherence Burden
Jan 09, 2009 1500 mg Daily Led_efficacy_2Led_efficacy_2Led_defaultLed_default ModerateModerateModerateModerate AlwaysAlwaysAlwaysAlways SomewhatSomewhatSomewhatSomewhat
Date
Jan 09, 2009
Advice & Tips
not enough

About Madopar (Prescription Drug)

Madopar is an international brand name for the combination of levodopa and benserazide. Levodopa, a precursor molecule to dopamine, is an important neurotransmitter implicated in the underlying cause of Parkinson's disease. Benserazide allows levodopa to continue circulating in the body longer.

Learn more about Madopar in our Madopar Community Report.